Period of time： 2003年4期
Publisher： Elsevier
Founded in： 1976
Total resources： 2
ISSN： 0197-2456
Subject： R4 Clinical Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Controlled Clinical Trials,volume 24,issue 4
Menu
Access to resources
Recommend
Power analysis in randomized clinical trials based on item response theory
By Holman R., Glas C.A.W., de Haan R.J. in (2003)
Controlled Clinical Trials,volume 24,issue 4 , Vol. 24, Iss. 4, 2003-08 , pp.Sample size calculation for bioequivalence studies with high-order crossover designs
By Qu R.P., Zheng H. in (2003)
Controlled Clinical Trials,volume 24,issue 4 , Vol. 24, Iss. 4, 2003-08 , pp.The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics
By The BENEDICT Group in (2003)
Controlled Clinical Trials,volume 24,issue 4 , Vol. 24, Iss. 4, 2003-08 , pp.The Arthritis, Diet and Activity Promotion Trial (ADAPT): design, rationale, and baseline results
By Miller G.D., Rejeski W.J., Williamson J.D., Morgan T., Sevick M.A., Loeser R.F., Ettinger W.H., Messier S.P., for the ADAPT investigators in (2003)
Controlled Clinical Trials,volume 24,issue 4 , Vol. 24, Iss. 4, 2003-08 , pp.By Kyriakides T.C., Babiker A., Singer J., Cameron W., Schechter M.T., Holodniy M., Brown S.T., Youle M., Gazzard B., on behalf of the OPTIMA Study Team see Appendix in (2003)
Controlled Clinical Trials,volume 24,issue 4 , Vol. 24, Iss. 4, 2003-08 , pp.